Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples